Funding for this research was provided by:
Cooperative Research and Development Agreement (CRADA) between the NCI and NantBioScience. (N/A)
Intramural Research Program of the Center for Cancer Research, National Cancer Institute (N/A)
Received: 16 October 2018
Accepted: 27 February 2019
First Online: 21 March 2019
Ethics approval and consent to participate
: All in vivo experiments were approved by the NCI/NIH Animal Care and Use Committee (ACUC).
: Not applicable.
: Authors from the National Cancer Institute do not have any competing interests to disclose. S.A. is an employee and shareholder of Altor Bioscience (a NantWorks company).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.